PATENT CLAIM ANALYSIS

Application Number: 16372177
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-12
Patent Classification: ["514", "299000"]

Abstract:
The invention provides a chewable gel dosage form that contains at least one active agent and a method of administering such chewable gel dosage form to subjects to treat one or more indications associated with the active agent(s). In one embodiment, the invention provides a method for the temporary relief of symptoms to due hay fever and upper respiratory allergies comprising administering to a subject in need thereof a chewable gel dosage form comprising a therapeutically effective amount of loratadine and a gelling agent, wherein therapeutic efficacy is achieved under fasted or fed conditions.

Claim (Index 10):
The method of  claim 1 , comprising administering the dosage form to the subject under fed conditions, wherein the dosage form provides an AUC(0-t) and an AUC(0-inf) of loratadine of at least about 10 ng*hr/mL in the subject under fed conditions.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 100.0
- Lexical Diversity: 1.55385
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11846896', '12155250', '14882662', '16198645', '14511420']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7522486982611726
- 35 USC 102 Novelty (BERT): 0.561224935037325
- Combined Prediction Score: 0.7331463219387879
- Mean Citation Score: 343.454102
- Max Citation Score: 350.32
- Similarity Product: 254.19770597457887

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test